ScoreWhy is Parmax Pharma Ltd ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -10.08% and Operating profit at 0% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.66
2
The company has declared Negative results for the last 3 consecutive quarters
- NET SALES(Latest six months) At Rs 6.86 cr has Grown at -55.91%
- PAT(Q) At Rs -0.73 cr has Fallen at -87.2%
3
Stock is technically in a Mildly Bearish range
- Multiple factors for the stock are Bearish like RSI, MACD and KST
4
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -16.57%, its profits have fallen by -94.6%
5
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 0.10% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -16.57% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Parmax Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Parmax Pharma
321.64%
-0.18
92.02%
Sensex
-11.86%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-6.45%
EBIT Growth (5y)
-213.12%
EBIT to Interest (avg)
0.66
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.77
Sales to Capital Employed (avg)
2.44
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-28.89%
ROE (avg)
5.12%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
37
Price to Book Value
-15.56
EV to EBIT
-28.34
EV to EBITDA
-42.62
EV to Capital Employed
22.58
EV to Sales
5.79
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-97.46%
ROE (Latest)
Negative BV
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend20What is working for the Company
NET SALES(Latest six months)
At Rs 11.53 cr has Grown at 70.31%
PBDIT(Q)
Highest at Rs 0.83 cr.
PBT LESS OI(Q)
Highest at Rs 0.12 cr.
PAT(Q)
Highest at Rs 2.20 cr.
EPS(Q)
Highest at Rs 5.88
-3What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.83 times
NON-OPERATING INCOME(Q)
is 94.55 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Parmax Pharma
Profit After Tax (PAT) - Quarterly
At Rs 2.20 cr has Grown at 389.5%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Latest six months
At Rs 11.53 cr has Grown at 70.31%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 0.83 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 0.12 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 2.20 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 5.88
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Parmax Pharma
Non Operating Income - Quarterly
is 94.55 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
Debtors Turnover Ratio- Half Yearly
Lowest at 3.83 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
